glp-1 new york What the NY Times Got Right — and What It Missed — About Drugs GLP-1 for New York, NY

It appears Novo was tripped up by manufacturing issues, as the company said the FDA made requests related to the manufacturing process in its Complete Response Letter

There were still some hurdles for users to clear limited insurance coverage, up to $1,350 out-of-pocket monthly costs, fear of needles but in December, the FDA approved Wegovy in the form of a daily pill that has none of these issues

doi:10.1002/ohn.1209 Foundayo (Orforglipron) FDA Approved: What NJ Patients Should Know About the New GLP-1 Pill for Weight Loss The FDA approved Foundayo (orforglipron) on April 1, 2026 a new once-daily GLP-1 weight loss pill from Eli Lilly

Now, findings from mouse studies published in the Journal of Virology suggest the drugs could also benefit people with type 2 diabetes who develop pulmonary fibrosis months or years after contracting SARS-CoV-2, the virus that causes COVID-19

This table places Peak Wellness alongside other common options to show where its approach stands out and where trade-offs are unavoidable: Swipe to scroll the table below Real User Experience With Peak Wellness Because Peak Wellness is still a newer clinic, there are very few established reviews across major platforms